Clinical trials: What to know before you invest | Health & Wealth #9 (Episode in English)

When developing new therapies or medicines, there are many hurdles along the way to reaching the market. If you do, that is. Failure is lurking at every step. A drug candidate must be safe and show clinicial efficacy in patients without severe side effects. The risks are significant and so are the costs, but if a project is successful, the reward could be enormous. So, how can you assess the risks involved?

In this episode of Health & Wealth Jesper Prior Larsen from Aixial Group – a leading experts at clinical trials – walk us through some of the things you need to be aware of before investing in life science.

Watch the interview at biostock.se:

https://www.biostock.se/health-and-wealth/?utm_source=mail&utm_medium=mail&utm_campaign=hw&utm_id=hw

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se